| 12187713 |
Immunomodulators, compositions and methods thereof |
Yiqian Wang, Yao ZHANG, Bang FU, Lieming DING |
2025-01-07 |
|
| 12043622 |
Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof |
Yiqian Wang, Chunhui Zhang, Lieming DING |
2024-07-23 |
|
| 11845762 |
Compound functioning as bromodomain protein inhibitor, and composition |
Yan Xu, Xiaofeng Xu, Lieming DING |
2023-12-19 |
|
| 11466013 |
ERK inhibitor and use thereof |
Hao Wu, Wei Gu, Xiaojing Tang, Wei Wang, Bo ZHAN +8 more |
2022-10-11 |
|
| 11466034 |
Compound functioning as bromodomain protein inhibitor, and composition |
Yan Xu, Xiaofeng Xu, Lieming DING |
2022-10-11 |
|
| 11447492 |
ERBB receptor inhibitors |
Zhengtao LI, Wei Zhong, Qingbei Zeng, Honchung Tsui, Zhenfan Yang +1 more |
2022-09-20 |
|
| 11365196 |
FGFR inhibitor and application thereof |
Xiaofeng Xu, Lieming DING, Xiangyong LIU |
2022-06-21 |
|
| 11053238 |
Benzimidazole derivatives, preparation methods and uses thereof |
Yiqian Wang, Lieming DING |
2021-07-06 |
|
| 10822334 |
ErbB receptor inhibitors |
Zhengtao LI, Wei Zhong, Qingbei Zeng, Honchung Tsui, Zhenfan Yang +1 more |
2020-11-03 |
|
| 10484272 |
Packet forwarding in RPR network |
Wenjun Du, Zhixin Xiong |
2019-11-19 |
$6,005,000 |
| 9718806 |
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor |
David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang |
2017-08-01 |
$34,361,000 |
| 9375432 |
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor |
David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang |
2016-06-28 |
$17,840,000 |
| 9066979 |
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor |
David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang |
2015-06-30 |
$17,347,000 |
| 8691825 |
Inhibitors of AKT activity |
Qi Chen, Mingxiang Cui, Bin Hu, Shuangxi Hu, Zhifa Pu +6 more |
2014-04-08 |
$55,924,000 |
| 8536193 |
Inhibitors of AKT activity |
Hidetomo Furuyama, Yasuhiro Goto, Nobuhiko Kawanishi, Mark E. Layton, Takashi Mita +5 more |
2013-09-17 |
$100,184,000 |
| 8207169 |
Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D |
Hidetomo Furuyama, Yasuhiro Goto, Nobuhiko Kawanishi, Mark E. Layton, Takashi Mita +6 more |
2012-06-26 |
|
| 8008317 |
Inhibitors of akt activtiy |
Donna J. Armstrong, Essa Hu, Michael J. Kelly, III, Mark E. Layton, Yiwei Li +4 more |
2011-08-30 |
$42,029,000 |
| 7763659 |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more |
2010-07-27 |
$110,666,000 |
| 7629367 |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more |
2009-12-08 |
$88,079,000 |
| 7625919 |
4-azasteroid derivatives as androgen receptor modulators |
Carol A. McVean |
2009-12-01 |
$78,669,000 |
| 7482359 |
Androgen receptor modulators |
Joshua Close |
2009-01-27 |
$37,804,000 |
| 7402577 |
Androstane 17-beta-carboxamides as androgen receptor modulators |
Mark E. Duggan, David B. Whitman |
2008-07-22 |
$246,702,000 |
| 7268153 |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more |
2007-09-11 |
$152,390,000 |
| 7109191 |
Benzazepinone alpha vintegrin receptor antagonists |
Robert S. Meissner, Paul J. Coleman, Mark E. Duggan, George D. Hartman, John Howard Hutchinson |
2006-09-19 |
$69,070,000 |
| 7056909 |
Alpha v integrin receptor antagonists |
— |
2006-06-06 |
$96,639,000 |
